Fine Mark National Bank & Trust Novo Nordisk A S Transaction History

Fine Mark National Bank & Trust

$2.84 Billion
Q3 2024

A detailed history of Fine Mark National Bank & Trust transactions in Novo Nordisk A S stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 5,066 shares of NVO stock, worth $442,616. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,066

Previous 5,483 7.61%

Holding current value

$442,616

Previous $782,000 22.89%

% of portfolio

0.02%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $49,652 - $60,640	-417 Reduced 7.61%	5,066 $603,000
Q2 2024 Aug 02, 2024	SELL	$122.71 - $146.91 $413,900 - $495,527	-3,373 Reduced 38.09%	5,483 $782,000
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $213,307 - $283,936	2,089 Added 30.87%	8,856 $1.14 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $26,597 - $31,951	303 Added 4.69%	6,767 $700,000
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $309,377 - $678,835	3,402 Added 111.1%	6,464 $587,000
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $9,826 - $10,876	63 Added 2.1%	3,062 $495,000
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $14,160 - $17,027	-107 Reduced 3.44%	2,999 $477,000
Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $14,151 - $18,675	-138 Reduced 4.25%	3,106 $420,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $66,124 - $81,149	694 Added 27.22%	3,244 $323,000
Q2 2022 Aug 09, 2022	SELL	$103.24 - $121.81 $42,741 - $50,429	-414 Reduced 13.97%	2,550 $284,000
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $9,961 - $12,041	107 Added 3.75%	2,964 $329,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $432,322 - $527,913	-4,509 Reduced 61.21%	2,857 $320,000
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $31,741 - $40,089	-376 Reduced 4.86%	7,366 $707,000
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $18,268 - $22,885	270 Added 3.61%	7,742 $649,000
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $304,586 - $344,374	4,542 Added 155.02%	7,472 $504,000
Q4 2020 Feb 10, 2021	SELL	$63.89 - $73.8 $233,454 - $269,665	-3,654 Reduced 55.5%	2,930 $205,000
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $28,405 - $31,318	-446 Reduced 6.34%	6,584 $457,000
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $6,439 - $7,473	-110 Reduced 1.54%	7,030 $460,000
Q1 2020 May 06, 2020	BUY	$49.46 - $64.78 $353,144 - $462,529	7,140 New	7,140 $430,000
Q4 2019 Feb 07, 2020	SELL	$49.86 - $58.26 $240,225 - $280,696	-4,818 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $11,552 - $12,983	-243 Reduced 4.8%	4,818 $249,000
Q2 2019 Aug 08, 2019	BUY	$46.79 - $52.47 $18,949 - $21,250	405 Added 8.7%	5,061 $258,000
Q1 2019 May 07, 2019	SELL	$46.36 - $52.63 $178,161 - $202,257	-3,843 Reduced 45.22%	4,656 $244,000
Q4 2018 Feb 07, 2019	BUY	$41.54 - $47.25 $166,118 - $188,952	3,999 Added 88.87%	8,499 $392,000
Q3 2018 Nov 02, 2018	BUY	$46.76 - $51.24 $210,420 - $230,580	4,500 New	4,500 $212,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.

Account

Fine Mark National Bank & Trust Novo Nordisk A S Transaction History